2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2019 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 18.600.000 | 1.829.059 | 1 | ||
2020 | 0 | 16.213.833 | 677.636 | 2 | ||
2019 | 0 | 150.000 | 21.250 | 1 |
Total number of partners: 70
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 67
Frequent / Rare Partner Ratio: 0.04
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-09-01 | Innovations to accelerate vaccine development and manufacture | Inno4Vac | participant | 18.600.000 | 41 |
2020-08-01 | Indo-European Consortium for Next Generation Influenza Vaccine Innovation | INCENTIVE | participant | 9.974.294 | 21 |
2020-01-01 | Effective combinational treatment of chronic pain in individual patients, by an innovative quantitative systems pharmacology pain relief approach. | QSPainRelief | participant | 6.239.539 | 10 |
2019-08-01 | TArgeTed molecular Imaging and surgery for gastro-intestinal Cancer | TAcTIC | participant | 150.000 | 2 |